Approved for SIGNIFOR LAR is a somatostatin analog indicated for the treatment of: Patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. ( 1.1 ) Patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative. ( 1.2 ). SIGNIFOR LAR is an injectable cyclohexapeptide, somatostatin analog. Pasireotide…
Loading full data from Know Your Drugs Institute…